Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Ourobio
Ourobio
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Ourobio
Revenue
$114.5 K
FY, 2023
Ourobio Summary
Company Summary
Overview
Ourobio (also known as Transfoam) is a synthetic biology, biomaterials, and circular economy company. It develops engineered microorganisms to turn industrial byproducts into biomaterials.
Type
Private
Status
Active
Founded
2020
HQ
Indianapolis, IN, US
|
view all locations
Website
https://www.ourobio.com/
Cybersecurity rating
Sectors
Manufacturing & Industrial
advanced materials
biotech
sustainability
Homepage
Linkedin
twitter
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Indianapolis, IN
HQ
United States
1210 Waterway Blvd Ste. 2000
Ourobio Financials
Summary Financials
Revenue (FY, 2023)
$114.5K
Gross profit (FY, 2023)
$99.0K
Net income (FY, 2023)
($118.2K)
Cash (FY, 2023)
$83.2K
EBIT (FY, 2023)
($148.3K)
Competitors and Similar Companies
Genomatica
Manufacturing & Industrial - Private
Pond
Manufacturing & Industrial - Private
ZymoChem
Manufacturing & Industrial - Private
Aequor
Manufacturing & Industrial - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top